• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Social Work Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Med Fact Book App
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Does CBT Enhance Pharmacotherapy for Addiction?

Does CBT Enhance Pharmacotherapy for Addiction?

July 3, 2021
Jedidiah Perdue, MD, MPH
From The Carlat Addiction Treatment Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Jedidiah Perdue, MD, MPH Dr. Perdue has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

REVIEW OF: Ray LA et al, JAMA Network Open 2020;3(6):e208279

Does cognitive behavioral therapy (CBT) provide any extra benefit when added to medication treatment for substance use disorders? It’s not clear. Most notably, in the COMBINE study of comparative treatments for alcohol use disorder (see CATR, Nov/Dec 2019), a combined behavioral intervention (that included CBT) added to medical management did not improve outcomes. And yet, in real-world practice, CBT continues to be widely offered. Recognizing this evidence gap in common practice and clinical guidelines, Ray et al did a systematic review and meta-analysis of combined CBT and pharmacotherapy for various substance use disorders.

The researchers searched over 10,000 abstracts to identify 30 studies meeting their inclusion criteria: peer-reviewed, English-language RCTs involving adults receiving either individual or group CBT in addition to medication. Trials mostly included alcohol, cocaine, and opioid use disorders, and medications trialed included naltrexone, disulfiram, nefazodone, desipramine, methadone, buprenorphine, acamprosate, and levodopa. The results were grouped according to three main questions, and an estimate of effect size was reported using Hedges’ g (0.2 small, 0.5 medium, 0.8 large).

The researchers found that CBT plus medications was somewhat superior to usual care interventions plus medications. These “usual care interventions” included basic medication clinic add-ons like clinical management, drug counseling, and group counseling. CBT was better than these basic interventions at reducing both the frequency (g = 0.18) and quantity (g = 0.28) of substance use.

That was the good news for CBT. The bad news was that CBT was not more effective than other specific forms of therapy (eg, motivational enhancement therapy, 12-step facilitation, contingency management [g = 0.05]) and did not demonstrate benefit when included as an add-on to medical management, such as in the COMBINE trial (g = 0.06–0.17).

CATR’s TAKE
This review shows that CBT is at best modestly effective when started alongside medications but not superior to other forms of psychotherapy or when added to medical management. However, before souring on CBT, it’s important to note that this meta-analysis tried to combine many studies of different disorders and medications with varying efficacy. While we wait for more data that match CBT with specific medications for specific substance use disorders, it is reasonable to offer CBT given its low risk and some likelihood that it may build capacity for recovery.
Addiction Treatment
KEYWORDS adjunct-treatment cognitive_behavioral_therapy psychotherapy
    Jedidiah Perdue, MD, MPH

    Treating Agitation in ICU Patients with AUD?

    More from this author
    www.thecarlatreport.com
    Issue Date: July 3, 2021
    SUBSCRIBE NOW
    Table Of Contents
    Does CBT Enhance Pharmacotherapy for Addiction?
    Starting Buprenorphine: Is Timing Everything?
    Cannabidiol for Crack-Cocaine Craving: Negative Findings
    Nicotine Patch for Cannabis Withdrawal?
    Breastfeeding and Addiction
    The Pregnant Patient With Substance Use Disorder
    Naloxone Prescribing
    A New High-Dose Naloxone: Life Saver or Punishment?
    CME Post-Test - Addiction in Pregnancy, CATR, July/August 2021
    DOWNLOAD NOW
    Featured Book
    • OUDFB1e_Cover_Binding.png

      Treating Opioid Use Disorder—A Fact Book (2024)

      All the tools you need to assess and treat patients struggling with opioid use disorder. 
      READ MORE
    Featured Video
    • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
      General Psychiatry

      KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

      Read More
    Featured Podcast
    • shutterstock_2622607431.jpg
      General Psychiatry

      Should You Test MTHFR?

      MTHFR is a...
      Listen now
    Recommended
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png

    About

    • About Us
    • CME Center
    • FAQ
    • Contact Us

    Shop Online

    • Newsletters
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN Self-Assessment Courses

    Newsletters

    • The Carlat Psychiatry Report
    • The Carlat Child Psychiatry Report
    • The Carlat Addiction Treatment Report
    • The Carlat Hospital Psychiatry Report
    • The Carlat Geriatric Psychiatry Report
    • The Carlat Psychotherapy Report

    Contact

    carlat@thecarlatreport.com

    866-348-9279

    PO Box 626, Newburyport MA 01950

    Follow Us

    Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

    © 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.